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Abstract
Chronic allergic asthma is characterized by Th2-polarized inflammation and leads to airway remodeling and fibrosis but the
mechanisms involved are not clear. To determine whether epithelial-mesenchymal transition contributes to airway
remodeling in asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite
(HDM) extract for up to 15 consecutive weeks. We report that respiratory exposure to HDM led to significant airway
inflammation and thickening of the smooth muscle layer in the wall of the large airways. Transforming growth factor beta-1
(TGF-b1) levels increased in mouse airways while epithelial cells lost expression of E-cadherin and occludin and gained
expression of the mesenchymal proteins vimentin, alpha-smooth muscle actin (a-SMA) and pro-collagen I. We also observed
increased expression and nuclear translocation of Snail1, a transcriptional repressor of E-cadherin and a potent inducer of
EMT, in the airway epithelial cells of HDM-exposed mice. Furthermore, fate-mapping studies revealed migration of airway
epithelial cells into the sub-epithelial regions of the airway wall. These results show the contribution of EMT to airway
remodeling in chronic asthma-like inflammation and suggest that Th2-polarized airway inflammation can trigger invasion of
epithelial cells into the subepithelial regions of the airway wall where they contribute to fibrosis, demonstrating a previously
unknown plasticity of the airway epithelium in allergic airway disease.
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Introduction
Allergic asthma is caused by respiratory exposure to common
aeroallergens like house dust mite (HDM) and results in reversible
airway obstruction, chronic Th2-polarized inflammation and
damage to the airway epithelium [1,2]. These events have been
associated with a dysregulated repair process, which is character-
ized by elevated expression of TGF-b and EGF and ultimately
results in airway fibrosis and lung dysfunction [3]. Epithelial-to-
mesenchymal transition (EMT) is an important mechanism during
development and cancer progression whereby epithelial cells gain
the capacity to migrate out of their context through down-
regulation of epithelial markers, such as junction proteins and
cytokeratins, and gained expression of mesenchymal proteins, such
as vimentin and a-SMA [4,5]. EMT also results in the acquisition
of stem cell features, linking EMT to the generation of cancer stem
cells [6,7]. Transforming growth factor-beta (TGF-b) is a major
inducer of EMT [4,8] and is secreted by various cells including
infiltrating immune cells [9,10]. TGF-b-induced EMT is driven by
transcription factors including Smad, Snail, Zeb, Twist and AP-1,
which form complexes that either repress epithelial genes or
activate mesenchymal genes [6,8,11,12]. TGF-b has also been
shown to synergize with EGF to induce EMT in various cell types
[13,14].
It has been postulated that EMT can be triggered under
inflammatory conditions and contribute to cancer metastasis and
organ fibrosis [4,5,15,16]. Th2 lymphocytes can enhance the
spread of tumor cells to distal sites via the activation of TGF-b-
and EGF-expressing tumor-associated macrophages [3,17] sug-
gesting that a Th2-polarized immune response may promote
tumor cell dissemination [18]. Previous in vitro studies have
demonstrated that HDM proteins can cooperate with TGF-b and
EGF to promote EMT in cultured airway epithelial cells by
stimulating internalization of E-cadherin [19], cleavage of junction
proteins [20] and activation of the protease-activated receptor
PAR-2 [21]. However, it is currently not known whether EMT
contributes to airway remodeling in asthma and whether chronic
allergic inflammation is sufficient to trigger this process.
In this study, we asked if EMT could contribute to airway
remodeling in a chronic Th2-polarized inflammatory microenvi-
ronment driven by respiratory aeroallergen exposure. We
evaluated this process by employing airway epithelial cell-fate
tracking in mice with chronic allergic asthma induced by exposure
to house dust mite extract (HDM), a common environmental
aeroallergen. We have identified EMT as a significant contributor
to airway wall thickening in severe asthma and confirmed the role
of TGF-b and EGF signaling in dysregulated repair processes in
the lung.
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Methods
Animals
Reporter mice were constructed by crossing Rosa26stop-LacZ
reporter mice (B6;129S4-Gt(ROSA)26Sortm1Sor/J; Jackson La-
boratoies) with mice expressing Cre under the surfactant protein C
(SPC) promoter (SPC-Cre, generously provided by Brigid Hogan
at Duke University Medical Center) to generate transgenic mice
stably expressing LacZ in lung epithelial cells (SPC-Cre;R26stop-
LacZ). Male and female mice were bred in-house at the
Karolinska Institutet animal facility at the Department of
Mikrobiologi, Tumo¨r- och Cellbiologi (MTC) and initiated into
experiments at 8–12 weeks of age. Mice were housed under
specific pathogen-free conditions following a 12-h light-dark cycle
and were provided food and water ad libitum. Mice were exposed
to purified HDM whole-body extract (Greer Laboratories, Lenoir,
North Carolina, USA) intranasally (25 mg protein in 10 mL saline)
under inhaled anesthesia (Isoflurane; Baxter Chemical, Kista,
Sweden) for five consecutive days, followed by two days rest, for
five, ten or fifteen consecutive weeks. Negative control animals
were administered 10 mL saline intranasally daily on the same
schedule. No exogenous adjuvant was given at any time. All
experiments described in this study were approved by the
Research Ethics Committee at the Karolinska Institute.
Collection and measurement of specimens
72 hours after the last allergen administration, mice were
anesthetized with fluanison/fentanyl/midazolam (0.1 mL/10 g
body weight i.p.), followed by full-body perfusion with PBS via
the left cardiac ventricle. Bronchoalveolar lavage fluid (BAL) was
collected by dissection of the lungs and cannulation of the trachea
with polyethylene tubing (Becton Dickinson, Sparks, MA). Briefly,
the lungs were lavaged twice with PBS (0.25 mL followed by
0.2 mL). Approximately 0.3 mL of the instilled fluid was
consistently recovered. Total cell counts in BAL fluid were
performed using a Countess automated cell counter (Invitrogen).
After centrifugation, cell pellets were resuspended in PBS and
smears were prepared by cytocentrifugation (Sakura Finetek
Europe BV, Zoeterwoude, the Netherlands) at 300 rpm for 2
minutes. Smears were fixed, stained with hematoxylin and eosin
and differential counts of BAL cells were determined from at least
300 leukocytes using standard hematological criteria to classify
them as mononuclear cells, neutrophils or eosinophils.
Cell Culture
A549 cells (ATCC, Manassas, VA) and 16HBE14o- cells (kindly
provided by Dr. D.C. Gruenert, University of California, San
Francisco) were cultivated in Ham’s F12 medium or Minimum
Essential Medium (MEM; Invitrogen, Stockholm, Sweden),
respectively, supplemented with 1% penicillin/streptomycin, 1%
L-glutamine and 10% fetal bovine serum (FCS; Invitrogen). Prior
to the addition of growth factors, cells were transferred into low
serum medium (1% FCS) and subsequently treated with 10 ng/
mL TGF-b (R&D Systems, Abingdon, UK) and/or 50 ng/mL
EGF (R&D Systems) for 72 h. Cells were then fixed for
immunofluorescent staining or lysed for RNA analysis.
Immunofluorescent staining of cultured cells
Cells which had been grown on coverslips in a 12-well plate
were fixed in absolute ethanol for 15 min at RT (for the detection
of junction proteins) or 3% PFA for 20 min at RT (for the
detection of transcription factors), washed three times with PBS
and quenched with 10 mM glycine for 20 min at RT. Following
two additional PBS washes, cells to be stained for Snail1/pSmad3
were permeabilized with 0.1% Triton-X in PBS for 30 min at RT,
washed twice with PBS, then treated with 8 M urea in PBS for
3 min at RT. Following two more PBS washes, cells were
incubated in blocking buffer (PBS with 0.1% BSA and 5% normal
goat serum) for 30 min RT, then incubated with primary
antibodies diluted in PBS with 0.1% BSA for 60 min RT. The
primary antibodies used in this analysis were: rabbit anti-CAR
(1:500), mouse anti-E-cadherin (1:500; clone 36, BD Biosciences),
mouse anti-vimentin (1:50, 3B4, DAKO), rat anti-occludin (1:3,
clone MOC37), mouse anti-SNAIL1 (1:3) and rabbit anti-
phosphorylated Smad3 (1:100; #9520, Cell Signaling Technolo-
gy, Danvers, MA). Cells were washed twice with PBS with 0.1%
BSA, then incubated with secondary antibodies for 30 min at RT.
The species-specific fluorescently-labeled secondary antibodies
used in this study were: DyLightTM 488-conjugated goat anti-
rabbit IgG, DyLightTM 488-conjugated goat anti-rat IgG and
DyLightTM 549-conjugated goat anti-mouse IgG; all used 1:500
from Jackson ImmunoResearch Europe Ltd., Newmarket, UK.
Following two washes in PBS with 0.1% BSA and two final washes
with PBS, coverslips were removed from the wells, mounted and
imaged on a Nikon Eclipse E800 microscope.
Semi-quantitative real-time PCR
Total RNA was isolated from A549 and 16HBE14o- cells and
purified using the RNeasy Mini Kit (Qiagen, Stockholm, Sweden),
supplemented with the RNase-Free DNase Set (Qiagen). RNA
from blood was purified using the the mouse RiboPureTM-blood
RNA Isolation Kit (Ambion). cDNA was obtained using the
iScript Select cDNA Synthesis Kit (Bio-Rad Laboratories AB,
Stockholm, Sweden), and the absence of DNA contamination was
verified by excluding the reverse transcriptase from subsequent
PCR reactions. cDNA aliquots were subjected to PCR using the
QuantiTect SYBR Green PCR Kit (Qiagen) to amplify human
CAR, occludin, E-cadherin, vimentin, SNAIL1, a-smooth muscle
actin (a-SMA) and GAPDH with primers using QuantiTect
Primer Assays (Qiagen). Each PCR reaction was carried out as
follows: 15 min at 95uC, 15 sec at 94uC, 30 sec at 55uC, and
30 sec at 72uC. Each cycle was repeated 35 times following the
manufacturer’s recommendations using a Rotorgene RG-3000A
thermal cycler, and Rotorgene 6.0 software (Corbett Research,
Umea˚, Sweden). Based on the comparative Ct method, gene
expression levels were calculated and GAPDH was used as a
control gene. Untreated control samples for each cell line were set
to 100% and fold change in expression in following treatment are
represented as bar graphs 6 standard error of the mean.
Histology
Lungs were inflated with 1% paraformaldehyde via the trachea
and stored in 1% paraformaldehyde for an additional 30 minutes
before being transferred to PBS. The lungs were dissected away
from the trachea, cryopreserved in 30% sucrose overnight at 4uC,
embedded in OCT (Sakura) and cut at a thickness of 5 mm (for
hematoxylin and eosin staining) or 15 mm (for immunofluorescent
imaging). For hematoxylin and eosin staining, sections were fixed in
100% methanol and stained according to a standard protocol. Forr
immunofluorescent staining, sections were blocked with 5% normal
goat serum in PBS containing 0.1% BSA and 0.3% Triton-X for
1 hour at RT, then stained with the following primary antibodies:
chicken anti-b-galactosidase (1:500; ab9361, Abcam, Cambridge,
UK), rabbit anti-vimentin (1:500; ab45939, Abcam), rat anti-E-
cadherin (1:250; ab11512, Abcam), rabbit anti-occludin (1:500; 71–
1500, Zymed/Invitrogen), rabbit anti-procollagen I (1:500; gener-
ously provided by K. Tryggvason, Karolinska Institutet, Stockholm,
Sweden), rat anti-Snail1 (1:500; generously provided by K.-F.
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Becker, Technische Universita¨t Mu¨nchen, Munich, Germany),
rabbit anti-phosphorylated Smad3 (1:100; #9520, Cell Signaling
Technology, Danvers, MA) and CY3-conjugated mouse anti-a-
SMA (1:1000; clone 1A4, Sigma-Aldrich, St. Louis, MO).
The species-specific fluorescently-labeled secondary antibodies
used in this study were: DyLightTM 488-conjugated goat anti-
chicken IgY, DyLightTM 549-conjugated goat anti-rabbit IgG,
DyLightTM 549-conjugated goat anti-rat IgG, DyLightTM 649-
conjugated goat anti-rabbit IgG and DyLightTM 649-conjugated
goat anti-rat IgG; all used 1:500 from Jackson ImmunoResearch
Europe Ltd., Newmarket, UK. Isotype control staining for Snail/
pSmad3 was performed using rat IgG2a (BD Biosciences)
labeled with DyLightTM 549-conjugated goat anti-rat IgG and
an affinity-purified polyclonal rabbit IgG labeled with DyLightTM
649-conjugated goat anti-rabbit IgG. Negative control images
(with omission of the primary antibody) and istotype control
images for lung sections taken from either saline control mice or
from mice exposed to HDM for 15 weeks (as indicated) are shown
in Fig. S1. Tissues were imaged using a Zeiss LSM510 confocal
microscope and evaluated using LSM510 software.
Data analysis
Data were analyzed using GraphPad InStat (GraphPad Software,
Inc., La Jolla, CA), and are expressed as mean 6 SEM, unless
Figure 1. LacZ expression pattern in SPC-Cre;R26stopfl/fl-LacZ mice. (A) Model of chronic respiratory house dust mite (HDM) extract exposure.
Mice were administered sterile saline or 25 mg of HDM extract in a volume of 10 mL 5 days a week for up to 15 consecutive weeks. Mice were sacrificed
after 5, 10 or 15 weeks of HDM exposure. (B) Characterization of the reporter mice used in this study. Cre is expressed by the SPC promoter and removes
the floxed stop sequence in front of the gene for LacZ under the control of the ROSA26 promoter. Thus, all lung epithelial cells stably and irreversibly
express LacZ. (C–E) Enzymatic staining for b-galactosidase activity was performed on 15 mm-thick lung sections from (C) SPC-Cre;R26stopfl/fl-LacZ mice
exposed to saline, (D) R26stopfl/fl-LacZ mice exposed to HDM and (E) SPC-Cre;R26stopfl/fl-LacZ exposed to HDM. Scale bar 10 mm.
doi:10.1371/journal.pone.0016175.g001
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otherwise indicated. Results were interpreted using ANOVA
followed by the Tukey post hoc test (where applicable). Differences
were considered to be statistically significant when p,0.05.
Results
Generation of transgenic mice with permanently labeled
airway epithelial cells
To determine whether chronic allergic airway inflammation
caused by respiratory exposure to HDM extract (Fig. 1A) results
in EMT in vivo, we employed an established transgenic mouse
model in which mice expressing a LacZ reporter gene under the
Rosa26 promoter (B6;129S4-Gt(ROSA)26Sortm1Sor/J) were
crossed with mice expressing Cre recombinase by the human
surfactant protein C promoter (SPC-Cre), which is restrictively
active in bronchiolar and alveolar epithelial cells (Fig. 1B) [22].
This resulted in the generation of double transgenic mice (SPC-
Cre;R26stopfl/fl-LacZ), in which airway epithelial cells were
permanently labeled with LacZ (Fig. 1C), allowing us to track
the acquisition of mesenchymal markers in these cells in the
context of chronic allergic airway inflammation.
Induction of EMT in HDM-induced chronic airway
inflammation
Exposure to HDM extract lead to robust airway inflammation
(Fig. 2A), characterized by eosinophil infiltration after 5 weeks
(Fig. 2B) and neutrophil infiltration after 10 and 15 weeks of
allergen exposure (Fig. 2C), as previously described [23].
Histological analysis of lung tissue from these mice demonstrated
significant inflammation and epithelial damage associated with
HDM exposure (Fig. 2D–G). We also observed marked
thickening of the sub-epithelial contractile smooth muscle layer
tissue in HDM-exposed mice (Fig. 2H–K), a feature of chronic
allergic asthma [24] which can only be partially accounted for by
smooth muscle hyperplasia and infiltration of bone-marrow
derived myofibroblasts [25].
Immunofluorescent staining of lung sections revealed decreased
staining of occludin and E-cadherin and increased expression of
vimentin in the airway epithelium after 5 weeks of HDM exposure
(Fig. 3B, F) compared to control (Fig. 3A, E). These changes
were accentuated after 10 weeks and 15 weeks of HDM exposure
(Fig. 3C, D, G, H). Airway smooth muscle mass as determined
by immunostaining for a-SMA was significantly elevated at all
Figure 2. Prolonged respiratory HDM exposure induces inflammation. Mice were administered sterile saline or 25 mg of HDM extract in a
volume of 10 mL 5 days a week for 5, 10 or 15 consecutive weeks. (A–C) Bronchoalveolar lavage (BAL) analysis was performed to determine total
inflammatory cell infiltrate (A) and to differentiate between eosinophils (B) and neutrophils (C). * p,0.05 compared to saline control animals,
1 p,0.05 compared to mice exposed to HDM for 5 weeks and " p,0.05 compared to mice exposed to HDM for 10 weeks. Data represent mean
6 SEM, n = 10–15 mice per group from two independent experiments. (D–G) Chemical staining for hematoxylin and eosin was performed on 5 mm-
thick lung sections from (D) control mice exposed to saline, (E) mice exposed to HDM for 5 weeks, (F) 10 weeks or (G) 15 weeks. * indicate airway
lumen, closed arrows indicate the epithelium, open arrows indicate airway smooth muscle. (H–K) Immunofluorescent staining for a-smooth muscle
actin (a-SMA) was performed on 15 mm-thick lung sections from (H) control mice exposed to saline, (I) mice exposed to HDM for 5 weeks, (J) 10 weeks
or (K) 15 weeks. * indicate airway lumen. Scale bar 10 mm.
doi:10.1371/journal.pone.0016175.g002
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time points after HDM exposure (Fig. 3I). After 10 and 15 weeks
of HDM exposure, LacZ+/a-SMA+ cells were incorporated into
airway smooth muscle (arrows, Fig. 3C, D) and LacZ+/
vimentin+ cells were present in the sub-epithelium (arrows,
Fig. 3G, H). Quantification of LacZ+/vimentin+ cells demon-
strated that approximately one third of the vimentin-positive cell
population was positive for LacZ (Fig. 3J). Additionally,
expression of pro-collagen I was detected in the airway epithelial
cells of mice following 10 weeks of HDM challenge (Fig. 3K, L).
Chronic HDM exposure leads to TGF-b expression and
activation of TGF-b signaling pathways in the lung
epithelium
Bronchoalveolar lavage (BAL) analysis demonstrated a signifi-
cant and progressive increase in TGF-b1 protein levels in the
lavage fluid from mouse airways with sustained exposure to HDM
(Fig. 4 A). Activation of Smad-dependent TGF-b signaling
pathways was demonstrated by immunofluorescent localization
of phosphorylated Smad3 (p-Smad3) and Snail1 in the nuclei of
airway epithelial cells after 15 weeks of HDM exposure (Fig. 4E–
G) but not under baseline conditions (Fig. 4B–D).
Cooperative induction of EMT in airway epithelial cells by
TGF-b and EGF
Immunofluorescent analysis of 16HBE14o- cells, which usually
express high levels of the epithelial tight junction proteins
coxsackie and adenovirus receptor (CAR) and occludin and the
adherens junction protein E-cadherin, showed dramatically
reduced expression of these epithelial proteins after 72 h of
treatment with TGF-b/EGF (Fig. 5A, B, D, E). However, no effect
of TGF-b/EGF treatment was observed at the transcriptional level
for CAR or occludin (Fig. 5G, H), although E-cadherin mRNA
Figure 3. Prolonged respiratory HDM exposure induces epithelial-to-mesenchymal transition. Lung sections (15 mm thick) were
prepared from control mice and mice exposed to HDM for 5, 10 or 15 weeks and immunofluorescent staining for the co-expression of the LacZ
reporter in airway epithelial cells with a-SMA and occludin (A–D) and with vimentin and E-cadherin (E–H) was performed. Scale bars 10 mm.
Quantification of lung fibrosis was performed by morphometric analysis of lung sections stained for a-SMA (I) or LacZ and vimentin (J). * p,0.05
compared to saline control animals, 1 p,0.05 compared to mice exposed to HDM for 5 weeks. Data represent mean 6 SEM, n = 5 mice per group.
Additional lung sections were stained to detect procollagen I-producing cells in the airway wall in control mice and in mice exposed to HDM for 10
weeks (K, L).
doi:10.1371/journal.pone.0016175.g003
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was significantly reduced in cells treated with TGF-b/EGF
(Fig. 5I),. Expression of the mesenchymal protein vimentin
increased at the protein level (Fig 5E), and vimentin and a-SMA
mRNA levels also increased (Fig. 5J, K) in cells treated with TGF-
b/EGF for 72h. Additionally, nuclear accumulation of p-Smad3
and Snail1 was detected in 16HBE14o- cells during TGF-b/EGF-
induced EMT (Fig. 5F). Increased expression of Snail1 mRNA
was also observed in 16HBE14o- cells treated with TGF-b/EGF
(Fig. 5L).
Compared to 16HBE14o- cells, A549 airway epithelial cells
express significantly lower levels of the epithelial junction proteins
CAR, occludin and E-cadherin, which were further decreased
following treatment with TGF-b/EGF (Fig. 6A, B, D, E). This
decrease in epithelial junction proteins was also observed on the
mRNA level following TGF-b/EGF (Fig. 6G, H, I). A549 cells
also exhibited baseline expression of the mesenchymal protein
vimentin (Fig. 6B), which increased furher following treatment
with TGF-b/EGF on the the protein (Fig. 6E) and mRNA levels
(Fig. 6J). Expression of a-SMA mRNA also increased after TGF-
b/EGF treatment (Fig. 6K). Nuclear accumulation of p-Smad3
and Snail1 was detected in A549 cells at baseline (Fig. 6C) and
increased during TGF-b/EGF-induced EMT (Fig. 6F). More-
over, TGF-b/EGF treatment significantly increased the expression
of Snail1 mRNA in A549 cells (Fig. 6L).
Discussion
In this study, we sought to analyze the contribution of EMT to
airway remodeling in chronic Th2-polarized inflammation caused
by long-term exposure to HDM. We found that airway epithelial
cells gradually lost expression of junction proteins and gained
expression of mesenchymal proteins, indicative of EMT. Airway
epithelial cells undergoing EMT migrated into the subepithelium
of larger airways where they were incorporated in accumulating
smooth muscle bundles suggesting that EMT contributes to airway
remodeling.
The airway epithelium plays a significant role in the pathology
of allergic asthma, since these cells serve as a source of multiple
cytokines, chemokines, growth factors and other mediators that
contribute to the immune response against inhaled allergens
[26,27]. Furthermore, proteolytic components of allergens such as
Der p1 have been shown to damage the epithelial barrier by
cleaving epithelial tight junction components, thereby enhancing
allergen penetration and further exacerbating the immune
response [28]. Epithelial damage is also thought to contribute to
the development of a dysregulated repair phenotype in the lung,
which may lead to airway remodeling in chronic asthma [26,29].
HDM is a complex mixture of several hundred proteins that
represents what human asthmatics are sensitized and exposed to,
and is capable of initiating Th2-polarized allergic airway
inflammation in the absence of an exogenous adjuvant [30,31].
Long-term exposure to HDM in mice recapitulates many features
of human asthma, including airway hyperresponsiveness, airway
wall remodeling and chronic airway inflammation which transi-
tions from a predominantly eosinophilic to neutrophilic inflam-
matory profile as the disease progresses [23,31].
Quantification of the number of vimentin+/LacZ+ cells in the
airway wall indicated that a significant subset of mesenchymal cells
(approximately 30%) was derived from the epithelium. This is in
agreement with other studies, in which similar epithelial cell fate-
tracking experiments were performed to investigate the contribu-
tion of EMT in a mouse model of idiopathic lung fibrosis [32].
Additionally, we observed that, after 10 weeks of HDM exposure,
LacZ+ cells in the airway epithelium and subepithelium were
capable of producing pro-collagen I, showing that epithelial cells
that have progressed through EMT contribute to collagen
deposition and subepithelial fibrosis in asthma. Altogether, the
data demonstrate that EMT-derived mesenchymal cells signifi-
cantly contribute to airway wall remodeling in this mouse model of
asthma.
TGF-b was significantly upregulated in the lung following
allergen challenge, similar to what has been shown in previous
studies involving both humans and mice with allergic airway
disease [33,34,35]. This supports a role for TGF-b signaling in the
induction of EMT in HDM-induced airway inflammation. High
TGF-b levels in the bronchoalveolar lavage were associated with
evidence of EMT in the airway wall. Moreover, a significant
overlap between nuclear staining of p-Smad3 and Snail1 was
observed, suggesting that Snail1-Smad3/4 repressor complexes
could be involved in promoting EMT in airway epithelial cells
Figure 4. Activation of TGF-b signaling pathways following chronic HDM exposure. (A) Analysis of TGF-b levels in mouse bronchoalveolar
lavage (BAL) fluid in saline controls and mice exposed to HDM for 5, 10 or 15 weeks. BAL fluid was collected at the time of sacrifice and analyzed by
ELISA for the expression of mouse TGF-b1. * p,0.05 compared to saline control animals, 1 p,0.05 compared to mice exposed to HDM for 5 weeks.
Data represent mean 6 SEM, n= 8 per group from two independent experiments. (B–G) Immunofluorescent staining for the expression of LacZ, p-
Smad3 and Snail1 in lung sections from control mice and mice exposed to HDM for 15 weeks.
doi:10.1371/journal.pone.0016175.g004
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during HDM induced chronic airway inflammation, similar to
what has been shown in breast epithelial cells [12]. Based on these
findings, we hypothesize that the mechanism by which EMT
occurs during chronic allergic lung inflammation may include
elements important to TGF-b-mediated induction of EMT in both
cancer and fibrotic diseases.
We next investigated the effect of TGF-b stimulation on
cultured airway epithelial cells. In these experiments, TGF-b and
EGF co-stimulation induced EMT in human A549 lung
carcinoma cells, a well-established model of TGF-b-induced
EMT, and, to a lesser extent, in phenotypically normal human
bronchial epithelial (16HBE14o-) cells, a phenomenon which has
been previously shown in similar studies [19]. Interestingly, we
observed that stimulation with TGF-b alone had little effect on the
phenotype of 16HBE14o- cells, while this treatment alone resulted
in rapid progression to a mesenchymal phenotype in A549 cells
(data not shown). However, the addition of EGF to TGF-b
treatment in both cell lines resulted in indications of the acquisition
of mesenchymal characteristics on both the protein and mRNA
levels. Progression into EMT was incomplete in 16HBE14o- cells,
with some decrease of protein expression of the tight junction
components CAR and occludin, although no change was seen in
the mRNA levels of these epithelial markers. Conversely, E-
cadherin levels decreased at both the protein and mRNA levels,
demonstrating differential regulation of tight junctions and
adherens junctions during the initial stages of EMT. These cells
also demonstrated increased expression of the mesenchymal
markers vimentin and a-SMA, and of activated TGF-b signaling
evidenced by nuclear translocation of the EMT-associated
transcription factors Snail1 and phospho-Smad3 in treated cells.
However, these changes, at least on the protein level, were
comparatively mild to what was observed in A549 cells following
TGF-b/EGF treatment. These cells demonstrated profound
downregulation of all three epithelial junction proteins investigat-
ed, both at the protein and mRNA levels, along with a significant
upregulation of vimentin and nuclear translocation of Snail1 and
phospho-Smad3. Compared to changes in the mRNA expression
of mesenchymal proteins, the changes in vimentin, a-SMA and
Snail1 mRNA levels were relatively minor in A549 cells stimulated
with TGF-b/EGF, likely reflecting the already prominent baseline
Figure 5. Partial induction of EMT in 16HBE14o- cells. (A–I) Progression through EMT was evaluated in the phenotypically normal human lung
epithelial cell line 16HBE14o- 72 h after the addition of TGF-b1 (10 ng/mL) and EGF (50 ng/mL) to the culture medium. The epithelial junction
proteins CAR and E-cadherin (A, D), the tight junction protein occludin and the mesenchymal marker vimentin (B, E) as well as the EMT-associated
transcription factors pSmad3 and Snail1 (C, F) were assessed by immunofluorescent staining. Scale bar 10 mm. Quantification of the relative mRNA
expression of CAR (G), occludin (H), E-cadherin (I), vimentin (J), a-SMA (K) and Snail1 (L) was assessed by qPCR. * p,0.05 compared to untreated cells.
Data represent mean 6 SEM, n = 6 from two independent experiments.
doi:10.1371/journal.pone.0016175.g005
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expression of these markers. Taken together, these results
demonstrate that the induction of complete EMT is a gradual,
stepwise process, requiring coordinated action of signaling
pathways and transcription factors, and regulation of target genes
encoding epithelial junction proteins and mesenchymal proteins.
These findings lend support to the kinetics of EMT progression in
vivo, since we observed indications of EMT in the lungs of HDM-
exposed mice only at later, more severe stages of the disease (10
weeks of exposure). Further studies are certainly required to
investigate the mechanisms of airway wall remodeling at earlier
stages of the disease before EMT mechanisms significantly
contribute to the population of subepithelial mesenchymal cells
in the lung.
In summary, the results of this study provide evidence that
EMT contributes to airway remodeling in a mouse model of
asthma. Furthermore, they show that EMT during chronic
inflammation not only drives phenotypic changes in airway
epithelial cells, but also facilitates the migration of these cells to
subepithelial regions of the airway wall. Further investigations into
the altered migratory capacity of epithelial cells as a consequence
of EMT may provide additional mechanistic insight into the role
of inflammation in the metastatic spread of tumor cells.
Supporting Information
Figure S1 Negative control images for immunofluorescent
staining. Lung sections from mice exposed to HDM for 15 weeks
(A–D) and were stained with the indicated secondary antibodies
and imaged under the same conditions as the images in the main
body of the study. Isotype control images were stained and imaged
under the same conditions as the Snail/pSmad3 images in Fig. 4B–
G, but with a rat IgG2a antibody in place of the Snail antibody
and an affinity-purified rabbit polyclonal IgG in place of the
pSmad3 antibody. Scale bars indicate 10 mm.
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